FDTCX
Price
$29.09
Change
+$0.02 (+0.07%)
Updated
May 9 closing price
Net Assets
3.27B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

FDTCX vs RGAHX

Header iconFDTCX vs RGAHX Comparison
Open Charts FDTCX vs RGAHXBanner chart's image
Fidelity Advisor Diversified Stock C
Price$29.09
Change+$0.02 (+0.07%)
VolumeN/A
Net Assets3.27B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
FDTCX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDTCX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDTCX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. FDTCX (3.27B). RGAHX pays higher dividends than FDTCX: RGAHX (0.54) vs FDTCX (0.00). FDTCX was incepted earlier than RGAHX: FDTCX (20 years) vs RGAHX (9 years). FDTCX (1.60) is less costly to investors than RGAHX (0.44). FDTCX is a more actively managed with annual turnover of: 84.00 vs. RGAHX (25.00). FDTCX has a lower initial minimum investment than RGAHX: FDTCX (0) vs RGAHX (250). RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. FDTCX (-10.02). RGAHX return over 5 years is better than : 44.87 vs. FDTCX (21.87).
FDTCXRGAHXFDTCX / RGAHX
Total Expense Ratio1.600.44364%
Annual Report Gross Expense Ratio1.600.44364%
Fund Existence20 years9 years-
Gain YTD-6.523-2.478263%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.27B285B1%
Annual Yield % from dividends0.000.54-
Returns for 1 year-10.023.25-308%
Returns for 3 years10.4833.4031%
Returns for 5 years21.8744.8749%
Returns for 10 years28.83N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics